Parkinson's and action regulation study in Dallas
Part of Brain & nervous system clinical trials.
This study looks at how people with Parkinson's disease regulate their actions. It will test your behavior during 'on' periods (when medication is working well) to understand decision-making and movement control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Parkinson's disease from a movement disorder specialist.
- Your Parkinson's symptoms should clearly improve when you take levodopa medication (at least 30% better during 'on' periods).
- You must be willing and able to take part in behavioral experiments that can last up to 3.5 hours.
- You should not have significant vision or hearing problems that would interfere with the study tasks.
- You must not have other brain conditions like stroke, dementia, or serious memory loss (such as a MoCA score below 23).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This study looks at how people with Parkinson’s disease speak, move, and think to see whether these patterns can act like a “biomarker” (a measurable sign) of the disease. It also involves healthy volunteers to compare results.
This study looks at whether having more control or “autonomy” helps you learn new movement tasks. It may help researchers find ways to improve physical therapy training for people with Parkinson’s.
This trial looks at how analyzing hand movements might help doctors tell the difference between Parkinson's disease and other similar conditions early on. It may help improve diagnosis so patients get the right care sooner.
This is an observational study, meaning it doesn’t test a new drug—researchers mainly follow people to better understand moderate Parkinson’s disease and who may be good candidates for future cell therapy. If you have moderate symptoms that aren’t well controlled with tablets, this study may help inform better future treatments.
This trial examines how self-controlled practice affects motor learning and motivation in people with Parkinson's disease. It aims to determine if giving participants control over their practice schedule can improve their ability to learn and perform motor tasks.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.